Children’s Cancer Cause Honors Dr. Michael Link with 2025 Rosen Award

Photo by © ASCO/Max Gersh 2017

Now in its tenth year, the annual Rosen Award recognizes individuals who have made outstanding contributions in the fight against childhood cancer.

NEW YORK, NY, UNITED STATES, November 6, 2025 /EINPresswire.com/ -- Children’s Cancer Cause will honor Michael P. Link, MD, as the 2025 Leonard M. Rosen Memorial Research Award recipient at a special reception in New York City this evening. The award recognizes Dr. Link’s lifelong dedication to improving outcomes for children battling cancer.

Established in 2016, the Children’s Cancer Cause Rosen Award highlights individuals whose advocacy and groundbreaking work has advanced the care and treatment of children with cancer, the leading cause of death by disease among children in the United States. The award recognizes pioneers who turn research into action and hope for young patients and their families.

Dr. Link is the Lydia J. Lee Professor in Pediatric Oncology at the Stanford University School of Medicine. His research focus includes the biology and treatment of non-Hodgkin lymphomas and Hodgkin disease, as well as clinical management of bone and soft tissue sarcomas in children.

“Children’s Cancer Cause is proud to recognize Dr. Link’s advocacy and clinical research to improve care for pediatric cancer patients,” said Steve Wosahla, CEO of Children’s Cancer Cause. “Throughout his career, Dr. Link has been a steadfast champion for advancing public health and public policy to affect the lives of patients and their families. His clinical insights have contributed to better care delivery and remarkable advances in survival rates.”

Dr. Link is the only pediatric oncologist to have served as president of the American Society of Clinical Oncology. He has been an Associate Editor of the Journal of Clinical Oncology, and he served as Vice Chairman of the Pediatric Oncology Group, a legacy group to the Children’s Oncology Group. He has also served on the Oncologic Drugs Advisory Committee of the FDA and the Board of Scientific Advisors of the National Cancer Institute. Dr. Link is currently a member of the Children’s Cancer Cause board of directors.

Dr. Link joins an esteemed group of Rosen Award recipients recognized for advocating for childhood cancer patients as researchers in healthcare, economics of drug development, outcomes research, enhanced access to drugs, and survivorship.

The annual Rosen Award pays tribute to the late Leonard Rosen, Children’s Cancer Cause chairman and founding board member, for his many years of service to the cause of pediatric cancer. Leonard’s son Adam L. Rosen is the current chair of the Children’s Cancer Cause board of directors.

Learn more about the award and its former recipients at childrenscancercause.org/rosen-award.

# # #

Founded in 1999, Children’s Cancer Cause is a leading national advocacy organization dedicated to creating a brighter future for children with cancer, survivors, and their families. Children’s Cancer Cause promotes policies and programs that aim to accelerate the development of safer, more effective cancer therapies for children and better address the unique needs and lifelong health challenges experienced by childhood cancer survivors and their families.

Steve Wosahla
Children's Cancer Cause
+1 202-552-7392
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.